• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

    29.10 +0.14 (+0.48%)
    Streaming Delayed Price Updated: 10:09 AM EST, Feb 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about PROCEPT BioRobotics Corporation - Common Stock

    < Previous 1 2 3 Next >
    News headline image
    PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
    Aquablation therapy delivers similar symptom score reduction, superior ejaculatory function preservation, and superior continence preservation to laser enucleation in 80–180 mL prostates in a... 
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy
    Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes 
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
    Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia 
    Via MarketBeat
    News headline image
    Why Intuitive Surgical Stock is Dominating the Medical Sector
    Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However 
    Via MarketBeat
    News headline image
    PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy
    From PROCEPT BioRobotics
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.